Verified Nov 2026
Batteries & E-Mobility
·
Fremont, California
·
Since 2018
Alamar Biosciences is a proteomics company headquartered in Fremont, California, founded in 2018. It operates as a publicly traded firm (ticker: ALMR) with 200–500 employees and approximately $55.5 million in revenue. The company develops ultra-high sensitivity protein detection platforms for early disease detection, serving research institutions, biopharmaceutical companies, and healthcare providers in automotive, electric-vehicle, and medical sectors. Its NULISA™ technology and ARGO™ HT System enable analysis of protein biomarkers at attomolar concentrations in non-invasive biological fluids.
Alamar Biosciences, Inc. at a glance
Revenue
55.5M
Employees
200-500
Founded
2018
Headquarters
Fremont, California
Ownership
Publicly traded (NASDAQ: ALMR)
Certifications
ISO 13485
Industries
Automotive
Electric Vehicles
Medical
STABILITY SIGNALS
Established & strong
8 years in operation (founded 2018).
Publicly listed; no distress event on record.
Holds ISO 13485 certification(s) per public sources.
Overview
Alamar Biosciences is a proteomics company headquartered in Fremont, California, founded in 2018. It operates as a publicly traded firm (ticker: ALMR) with 200–500 employees and approximately $55.5 million in revenue. The company develops ultra-high sensitivity protein detection platforms for early disease detection, serving research institutions, biopharmaceutical companies, and healthcare providers in automotive, electric-vehicle, and medical sectors. Its NULISA™ technology and ARGO™ HT System enable analysis of protein biomarkers at attomolar concentrations in non-invasive biological fluids.
At a glance
Attribute | Detail |
|---|---|
Founded | 2018 |
Headquarters | Fremont, California |
Employees | 200-500 |
Revenue | 55.5M |
Ownership | Publicly traded (NASDAQ: ALMR) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 |
What Alamar Biosciences, Inc. makes
The company holds ISO 13485 certification and offers the NULISA™ Assay for high-sensitivity protein detection, the NULISAseq Inflammation Panel for immune and inflammatory disease profiling, and the ARGO™ HT System for automated high-throughput analysis.
Certifications
Alamar Biosciences, Inc. is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — alamarbio.com
Latest developments
2026-11-03 — Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine | Tue, 11/03/2026 - 16:03 (alamarbio.com)
2026-11-03 — Alamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue Guidance | Tue, 11/03/2026 - 16:05 (alamarbio.com)
2026-11-02 — Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study | Mon, 11/02/2026 - 08:00 (alamarbio.com)
2026-08-10 — Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures | Mon, 08/10/2026 - 16:03 (alamarbio.com)
2026-01-11 — Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team - Alamar Biosciences (alamarbio.com)
2025-10-15 — Alamar Biosciences Expands Executive Leadership to Power Next Phase of Growth - Alamar Biosciences (alamarbio.com)
Facilities
Alamar Biosciences, Inc. is headquartered in Fremont, California. Public sources also reference these locations:
Milan, Italy — alamarbio.com
Company details
Alamar operates a facility in Milan, Italy and has secured convertible notes financing as of January 2026. Alamar Biosciences, Inc. was founded in 2018, has an estimated 200-500 employees, and is headquartered in Fremont, California. On the LightSource stability read it is rated "Established & strong": 8 years in operation (founded 2018). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Alamar Biosciences, Inc. make?
Alamar Biosciences is a proteomics company headquartered in Fremont, California, founded in 2018. It operates as a publicly traded firm (ticker: ALMR) with 200–500 employees and approximately $55.5 million in revenue. The company develops ultra-high sensitivity protein detection platforms for early disease detection, serving research institutions, biopharmaceutical companies, and healthcare providers in automotive, electric-vehicle, and medical sectors. Its NULISA™ technology and ARGO™ HT System enable analysis of protein biomarkers at attomolar concentrations in non-invasive biological fluids.
Where is Alamar Biosciences, Inc. headquartered?
Alamar Biosciences, Inc. is headquartered in Fremont, California (47071 Bayside Parkway, Fremont, California, 94538).
When was Alamar Biosciences, Inc. founded?
Alamar Biosciences, Inc. was founded in 2018.
How big is Alamar Biosciences, Inc.?
Alamar Biosciences, Inc. has an estimated 200-500 employees, with revenue in the 55.5M range.
Is Alamar Biosciences, Inc. publicly traded?
Publicly traded (NASDAQ: ALMR). Public financial figures are drawn from its filings.
What certifications does Alamar Biosciences, Inc. hold?
Alamar Biosciences, Inc. lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.